Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Biological Methods for Microbial Control01:28

Biological Methods for Microbial Control

506
Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...
506
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

5.2K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
5.2K
Antibiotic Selection00:57

Antibiotic Selection

56.7K
Overview
56.7K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

535
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
535
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

262
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
262
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

664
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
664

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hyperbranched poly(β-amino ester)s-mediated delivery of engineered Klotho mRNA rescues senescence and restores cellular homeostasis in aged and Klotho deficient iMSCs.

Drug delivery and translational research·2026
Same author

Exploring climate smart agriculture in Turkey: Enhancing food security and sustainable practices for the reduction of CO₂ emissions.

PloS one·2026
Same author

Stem Cells and their Key Derivatives in Degenerative Musculoskeletal Diseases.

Stem cell reviews and reports·2026
Same author

Red Blood Cell-Derived Extracellular Vesicles for Gene and RNA Therapeutics: Biological, Engineering, and Translational Challenges.

International journal of nanomedicine·2026
Same author

Drugging the 'undruggable' KRAS: breakthroughs, challenges, and opportunities in pancreatic cancer.

Cancer biology & medicine·2025
Same author

Comparative effectiveness of silodosin vs. tamsulosin in treating acute urinary retention in benign prostatic hyperplasia patients.

JPMA. The Journal of the Pakistan Medical Association·2025

Related Experiment Video

Updated: Oct 26, 2025

Quantitative Polymerase Chain Reaction-based Analyses of Murine Intestinal Microbiota After Oral Antibiotic Treatment
08:33

Quantitative Polymerase Chain Reaction-based Analyses of Murine Intestinal Microbiota After Oral Antibiotic Treatment

Published on: November 17, 2018

13.3K

Targeted microbiome-sparing antibiotics.

Tim Avis1, Francis X Wilson1, Nawaz Khan1

  • 1Summit Therapeutics, Merrifield Centre, Rosemary Lane, Cambridge CB1 3LQ, UK.

Drug Discovery Today
|July 30, 2021
PubMed
Summary

Low research productivity has hindered antibiotic resistance solutions. Focusing on narrow-spectrum antibiotics preserves the gut microbiome, offering a more effective future R&D strategy.

Keywords:
AntibioticBroad-spectrumMicrobiomeNarrow spectrumNew mechanismTargeted

More Related Videos

Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation
08:34

Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation

Published on: July 27, 2022

965
Purifying the Impure: Sequencing Metagenomes and Metatranscriptomes from Complex Animal-associated Samples
11:23

Purifying the Impure: Sequencing Metagenomes and Metatranscriptomes from Complex Animal-associated Samples

Published on: December 22, 2014

37.4K

Related Experiment Videos

Last Updated: Oct 26, 2025

Quantitative Polymerase Chain Reaction-based Analyses of Murine Intestinal Microbiota After Oral Antibiotic Treatment
08:33

Quantitative Polymerase Chain Reaction-based Analyses of Murine Intestinal Microbiota After Oral Antibiotic Treatment

Published on: November 17, 2018

13.3K
Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation
08:34

Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation

Published on: July 27, 2022

965
Purifying the Impure: Sequencing Metagenomes and Metatranscriptomes from Complex Animal-associated Samples
11:23

Purifying the Impure: Sequencing Metagenomes and Metatranscriptomes from Complex Animal-associated Samples

Published on: December 22, 2014

37.4K

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Clinical antibiotic resistance presents a significant global health challenge.
  • Traditional research and development (R&D) has yielded limited progress, primarily incremental improvements to existing broad-spectrum antibiotics.
  • The human microbiome's role in health homeostasis is increasingly recognized, highlighting potential costs associated with broad-spectrum treatments.

Purpose of the Study:

  • To evaluate the limitations of current antibiotic R&D strategies.
  • To explore the potential of narrower-spectrum antibiotics as a more effective approach.
  • To emphasize the importance of the gut microbiome in guiding future antibiotic development.

Main Methods:

  • Review of current antibiotic R&D productivity and clinical pipeline.
  • Analysis of the impact of broad-spectrum versus narrow-spectrum antibiotics on the human microbiome.
  • Synthesis of emerging knowledge on the gut microbiome's role in health and disease.

Main Results:

  • Past R&D efforts have been characterized by low productivity and incremental advances.
  • Narrower-spectrum antibiotics offer targeted pathogen eradication while preserving beneficial microbial communities.
  • The gut microbiome's contribution to overall health suggests that broad-spectrum agents may have detrimental long-term effects.

Conclusions:

  • A shift towards narrower-spectrum antibiotic development is warranted due to low R&D returns from broad-spectrum agents.
  • Preserving the human microbiome through targeted antibiotic therapy is crucial for mitigating collateral health costs.
  • Future antibiotic R&D should integrate improved diagnostics, antibiotic stewardship, and a deeper understanding of the gut microbiome.